SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-18-002422
Filing Date
2018-02-21
Accepted
2018-02-21 06:05:23
Documents
8
Period of Report
2018-02-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 51213
2 ex3-1.htm EX-3.1 167823
3 ex3-1_1.htm EX-3.1.1 168098
4 ex4-1.htm EX-4.1 24540
5 ex10-1.htm EX-10.1 175244
6 ex10-2.htm EX-10.2 82873
7 ex99-1.htm EX-99.1 11266
8 ex99-1_001.jpg GRAPHIC 4663
  Complete submission text file 0001493152-18-002422.txt   689210
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21617 | Film No.: 18626975
SIC: 2834 Pharmaceutical Preparations